Description

Lagendijk et al studied different approaches for distinguishing between primary ovarian adenocarcinomas and metastatic tumors from the colon or breast in women. One approach was to traverse a decision tree using results of immunohistochemical staining as the basis for the decisions. The study was done at the Free University Hospital in Amsterdam, The Netherlands.


 

Immunohistochemical staining battery:

(1) GCDFP-15 (gross cystic disease fluid protein)

(2) ER (estrogen receptor)

(3) CEA (carcinoembryonic antigen)

(4) CK7 (cytokeratin 7)

Intensity of Staining

Points

none

0

mild

1

moderate

2

marked

3

 

immunohistochemical score =

= (percent of tumor staining as a whole number from 0 to 100) * (points for staining intensity)

 

where:

• minimum immunohistochemical score: 0

• maximum immunohistochemical score: 300

 

Decision Tree (Figure 1, page 287, as a Series of Rules)

 

Step 1: If the immunohistochemical score of the GCDFP-15 was > 10, then metastatic breast carcinoma.

 

Step 2: If the immunohistochemical score of the ER was > 95, then metastatic breast carcinoma.

 

Step 3: If the immunohistochemical score of the CEA was greater than the immunohistochemical score for CK7, then metastatic colon carcinoma.

 

Step 4: If all of the above are negative, then primary ovarian adenocarcinoma.

 


To read more or access our algorithms and calculators, please log in or register.